Ampio Pharmaceuticals launches clinical trial of Ampion for treatment of osteoarthritis of the hand

Ampio Pharmaceuticals launches clinical trial of Ampion for treatment of osteoarthritis of the hand

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced patient dosing has begun in the initial clinical trial of Ampion for the treatment of pain due to osteoarthritis of the... Read More

Tuesday May 10, 2016 0 comments Tags: Englewood, Ampio, Ampion, Michael Macaluso, Dr. David Bar-Or